Hyperglycosylated hCG, hCGβ and Hyperglycosylated hCGβ: Interchangeable cancer promoters

Molecular and Cellular Endocrinology

Volumn 349, Issue 2, 2012, Pages 232-238

  Cole, Laurence A ^a   Butler, Stephen ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b MIDDLESEX UNIVERSITY   (United Kingdom)

Author keywords

HCG; HCG ; Hyperglycosylated hCG

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ANTIBODY DETECTION; ARTICLE; BIOASSAY; CANCER CELL CULTURE; CARCINOGENESIS; CELL GROWTH; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN CELL; HYPERGLYCOSYLATION; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FUNCTION; ADENOCARCINOMA; APOPTOSIS; BLADDER TUMOR; CELL COUNT; CELL PROLIFERATION; CHORIOCARCINOMA; DRUG EFFECT; ENDOMETRIUM TUMOR; FEMALE; MALE; METABOLISM; NEOPLASM; PATHOLOGY; PREGNANCY; TESTIS TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; APOPTOSIS; CELL COUNT; CELL LINE, TUMOR; CELL PROLIFERATION; CHORIOCARCINOMA; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; ENDOMETRIAL NEOPLASMS; FEMALE; GLYCOSYLATION; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; PREGNANCY; TESTICULAR NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 84858161150     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.10.029     Document Type: Article

References (58)

1. Acevedo H.F., Hartstock R.J. Metastatic phenotype correlates with high expression of membrane-associated complete β-human chorionic gonadotropin in vivo. Cancer 1996, 78:2388-2399.
2. Alfthan H., Haglund C., Robets P., Stenman U.H. Evaluation of free β-subunit of human choriogonadotropin and core β-fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res. 1992, 53:4628-4633.
3. Bellet D., Lazar V., Bleche I., Paradis V., Giovangrandi Y., Paterliru P. Malignant transformation of nontrophoblastic cells in association with the expression of chorionic gonadotropin β genes normally transcribed in trophoblastic cells. Cancer Res. 1997, 57:516-523.
4. Birken S., Krichevsky A., O'Connor J., Schlatterer J.A., Kardana A., Cole L.A., Canfield R. Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinomahCG. Endocrine 1999, 10:137-144.
5. Butler S.A., Ikram M.S., Mathieu S., Iles R.K. The increase in bladder carcinoma cell population induced by the free beta subunit of hCG is a result of an anti-apoptosis effect and not cell proliferation. Brit. J. Cancer 2000, 82:1553-1556.
6. Butler S.A., Staite E.M., Iles R.K. Reduction of Bladder cancer cell growth in response to hCGβ vaccinated mouse serum. Oncol. Res. Anti Cancer Drug Des. 2003, 14:93-100.
7. Butler S.A., Iles R.K. Ectopic human chorionic gonadotrophin β secretion by epithelial tumors and human chorionic gonadotrophin β-induced apoptosis in Karposi's sarcoma, is there a connection?. Clin. Cancer Res. 2003, 9:4666-46732.
8. Butler S.A., Iles R.K. Biological function of the free ãÿ-subunit: expression and treatment target in cancer. Human Chorionic Gonadotropin (hCG) 2010, 153-172. Elsevier Inc, Burlington MA. L.A. Cole (Ed.).
9. Carter W.B., Sekharem M., Coppola D. Human chorionic gonadotropin induces apoptosis in breast cancer. Breast Cancer Res. Treat. 2006, 100:S243-S244.
10. Cole L.A., Hussa R.O. Use of glycosidase digested human chorionic gonadotropin β-subunit to explain the partial binding of glycoprotein hormones to Con A. Endocrinology 1981, 109:2276-2279.
11. Cole L.A. The O-linked oligosaccharides are strikingly different on pregnancy and choriocarcinomahCG. J. Clin. Endocrinol. Metab. 1987, 65:811-813.
12. Cole L.A., Birken S., Sutphen S., Hussa R.O., Pattillo R.A. Absence of the COOH-terminal peptide on ectopic human chorionic gonadotropin β-subunit (hCG-β). Endocrinology 1982, 110:2198-2200.
13. Cole L.A., Butler S.A., Khanlian S.A., Giddings A., Muller C.Y. Seckl MJ. Kohorn EI. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia. Gynecol. Oncol. 2006, 102:150-158.
14. Cole, L.A., 1994. Urinary Beta Core Fragment (β-core, UGP or UGF). Tumor Marker Upd. 6, 69-75.
15. Cole L.A., Sutton J.M., Higgins T.N., Cembrowski G.S. Between-method variation in hCG test results. Clin. Chem. 2004, 50:874-882.
16. Cole L.A., Dai D., Butler S.A., Leslie K.K., Kohorn E.I. Gestational trophoblastic diseases: 1. Pathophysiology of hCG-H-regulated neoplasia. Gynecol. Oncol. 2006, 102:144-149.
17. Cole L.A., Khanlian S.A., Riley J.M., Butler S.A. hCG-H (hCG-H) in gestational implantation, and in choriocarcinoma and testicular germ cell malignancy tumorigenesis. J. Reprod. Med. 2006, 51:919-929.
18. Cole L.A. hCG-H. Placenta 2007, 28:977-986.
19. Cole L.A., Khanlian S.A., Muller C.Y. Blood test for placental site trophoblastic tumor (PSTT) and for non-trophoblasticmalignancy for evaluating patients with low positive hCG results. J. Reprod. Med. 2008, 53:457-464.
20. Cole L.A., Laidler L., Muller C. USA hCG reference service, 10-year report. Clin. Biochem. 2010, 43:1013-1022.
21. Cosgrove D.E., Campain J.A., Cox G.S. Chorionic gonadotropin synthesis by human tumor cell lines: examination of subunit accumulation steady-state levels of mRNA and gene structure. Biochem. Biophys. Acta 1989, 1007:44-54.
22. Delves P.J., Iles R.K., Roitt I.M., Lund T. Designing a new generation of anti-hCG vaccines for cancer therapy. Mol. Cell. Endocrinol. 2007, 260-276. 281.
23. Elliott M.M., Kardana A., Lustbader J.W., Cole L.A. Carbohydrate and Peptide structure of the α- and β-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine 1997, 7:15-32.
24. Fisher S.J., Tian-yi C., Li Z., Hartman L., Grahl K., Zhang G.-Y., Tarpey J., Damsky C.H. Adhesive and degradative properties of human placental cytotrophoblast cell in vitro. J. Cell Biol. 1989, 109:891-902.
25. Gillott D.J., lles R.K., Chard T. The effects of β-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer 1996, 73:323-326.
26. Guibourdenche J., Handschuh K., Tsatsaris V., Gerbaud M.C., Legul F., Muller D., Evain-Brion D., Fournier T. hCG-His a marker of earlyhumantrophoblast invasion. J. Clin. Endocrinol. Metab. 2010, 95:E240-E244.
27. Handschuh K., Guibourdenche J., Tsatsaris V., Guesnon M., Laurendeau I., Evain-Brion D., Fournier T. Humanchorionicgonadotropin expression in humantrophoblastsfromearly placenta, comparative studybetweenvillous and extravilloustrophoblasticcells. Placenta 2007, 28:175-184.
28. Halila H., Alfthan H., Stenman U.H. Clinical use of gynaecological tumor markers. Annal. Chir. Gynaecol. 1989, 78:65-70.
29. Handschuh K., Guibourdenche J., Tsatsari V., Guesnon M., Laurendeau I., Evain-Brion D., Fournier T. Humanchorionic gonadotropin produced by the invasive trophoblast but not the villoustrophoblast promotes cell invasion and is down-regulated by peroxisomeproliferator-activatedreceptor-a. Endocrinology 2007, 148:5011-5019.
30. Hussa R.O., Fein H.G., Pattillo R.A., Nagelberg S.B., Rosen S.W., Weintraub B.D., Perini F., Ruddon R.W., Cole L.A. A distinctive form of human chorionic gonadotropin beta-subunit-like material produced by cervical carcinoma cells. Cancer Res. 1986, 46:1948-1954.
31. Hwang J.H., Koh S.H., Han D.I., Chung S.R., Park M.I., Hwang Y.Y., Jang S.J. Expression of transforming growth factor-1, 2 in the decidua of the early pregnancy: Comparison of decidua basalis and decidua parietalis. Korean J. Obstet. Gynecol. 2001, 44:1145-1149.
32. Iles R.K. Ectopic hCGβ expression by epithelial cancer: Malignant behaviormetastasis and inhibition of tumor cell apoptosis. Mol. Cell. Endocrinol. 2007, 260:264-270.
33. Iversen P.L., Mourich D.V., Moulton H.M. Monoclonal antibodies to two epitopes of β-human chorionic gonadotropin for the treatment of cancer. Cur. Opin. Mol. Thera. 2003, 5:156-160.
34. Kamijo T., Rajabi M.R., Mizunuma H., Ibuki Y. Biochemical evidence for autocrine/paracrine regulation of apoptosis in cultured uterine epithelial cells during mouse embryo implantation in vitro. Mol. Hum. Reprod. 1998, 4:990-998.
35. Khoo N.K., Bechberger J.F., Shepherd T., Bond S.L., McCrae K.R., Hamilton G.S., Lala P.K. SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype I Mechanisms responsible for hyperinvasiveness and resistance to anti-invasive action of TGFβ. Int. J. Cancer 1998, 77:429-439.
36. Kingsley-Kallesen M., Johnson L., Scholtz B., Kelly D., Rizzino A. Transcriptional regulation of the TGF-beta 2 gene in choriocarcinoma cells and breast carcinoma cells: differential utilization of Cis-regulatory elements. In Vitro Cell Dev. Bio. Anim. 1997, 33:294-301.
37. Knittel T., Mehde M., Kobold D., Saile B., Dinter C., Ramadori G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver regulation by TNF-alpha and TGF-beta1. J. Hepatol. 1999, 30:48-60.
38. Lapthorn A.J., Harris D.C., Littlejohn A., Lustbader J.W., Canfield R.E., Machin K.J. Crystal structure of hCG. Nature 1994, 369:455-461.
39. Laub M., Jennissen H.P. Identification of the anthelix motif in the TGF-β superfamily by molecular 3D-Rapid Prototyping. Materialwissenschaft und Werkstofftechnik 2003, 34:1113-1119.
40. Lehnert S.A., Ankhurst R.A. Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action. Development 1988, 104:263-273.
41. Li D., Wen X., Ghali L., Al-Shalabi F.M., Docherty S.M., Purkis P., Iles R.K. hCGβ expression by cervical squamous carcinoma - in vivo histological association with tumor invasion and apoptosis. Histopathology 2008, 53:147-155.
42. Liu Y.-X., Gao F., Wei P., Chen X.-L., Gao H.-J., Zou R.-Z., Siao L.-J., Xu F.-H., Feng Q., Liu K., Hu Z.-Y. Involvement of molecules related to angiogenesis, proteolysis and apoptosis in implantation in rhesus monkey and mouse. Contraception 2005, 71:249-262.
43. Martell R.E., Ruddon R.W. Patterns of human chorionic gonadotropin expression in untreated and 8-bromoadenosine-treated JAR choriocarcinoma cells. Endocrinology 1990, 126:2757-2764.
44. Mizuochi T., Nishimura R., Taniguchi T., Utsunomiya T., Mochizuki M., Derappe C., Kobata A. Comparison of carbohydrate structure between human chorionic gonadotropin present in urine of patients with trophoblastic diseases and healthy individuals. Jpn. J. Cancer Res. 1985, 76:752-759.
45. Morse M.A., Chapman R., Powderly J., Blackwell K., Keler T., Green J., Riggs R., He L.Z., Ramakrishna V., Vitale L., Zhao B., Butler S.A., Hobeika A., Osada T., Davis T., Clay T., Lyerly H.K. Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with toll-like receptor stimulation to induce immunity to self-antigens in cancer patients. Clin. Cancer Res. 2011, 17:4844-4853.
46. Moulton H.M., Yoshihara P.H., Mason D.H., Iversen P.L., Triozzi P.L. Active specific immunotherapy with β-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. Clin. Cancer Res. 2002, 8:2044-2051.
47. Murphy G., Reynolds J.J., Whitham S.E., Docherty A.J., Angel P., Heath J.K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. Eur. Mol. Biol. Org. J. 1987, 6:1899-1904.
48. Pampferf S. Apoptosis in rodent peri-implantation embryos, differential susceptibility of inner cell mass and trophectoderm cell lineages - a review. Placenta 2000, 21:S3-S10.
49. Pringle K., Roberts C. New light on early post-implantation pregnancy in the mouse: roles for insulin-like growth factor-II (IGF-II)?. Placenta 2007, 28:286-297.
50. Puisieux A., Bellet D., Troalen G., Razafindratsita A., Lhomme C., Bohoun C., Bidart J-M. Occurrence of fragmentation of free and combined forms of the β-subunit of human chorionic gonadotropin. Endocrinology 1990, 126:687-694.
51. Qureshi H.Y., Sylvester J., El Mabrouk M., Zafarullah M. TGF-beta-induced expression of tissue inhibitor of metalloproteinases-3 gene in chondrocytes is mediated by extracellular signal-regulated kinase pathway and Sp1 transcription factor. J. Cell Physiol. 2005, 203:345-352.
52. Regelson W. Have we found the " definitive cancer biomarker" ? The diagnostic and therapeutic implications of human chorionic gonadotropin-beta statement as a key to malignancy. Cancer 1995, 76:1299-1301.
53. Ruddon R.W., Norton S.E. Use of biological markers in the diagnosis of cancers of unknown primary tumor. Semin. Oncol. 1993, 20:251-260.
54. Schuster N., Krieglstein K. Mechanisms of TGF-β-mediated apoptosis. Cell Tissue Res. 2002, 307:1-14.
55. Shooner C., Caron P.C., Fréchette-Frigon G., Leblanc V., Déry M.-C., Asselin E. TGF-β expression during rat pregnancy and activity on decidual cell survival. Reprod. Biol. Endocrinol. 2005, 3:20.
56. Staun-Ram E., Shaleu E. Human trophoblast function during the implantation process. Reprod. Biol. Endocrinol. 2005, 3:56-68.
57. Stetler-Stevenson W.G., Brown P.D., Onisto M., Levy A.T., Liotta L.A. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 1990, 265:13933-13938.
58. Valmu L., Alfthan H., Hotakainen K., Birken S., Stenman U.H. Site-specific glycan analysis of human chorionic gonadotropin {beta}-subunit from malignancies and pregnancy by liquid chromatography - electrospray mass spectrometry. Glycobiology 2006, 16:1207-1218.